Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
|
A
|
ACS Actividades de Construccion y Servicios SA
XBER:OCI1
|
ES |
|
E
|
Equinor ASA
SWB:DNQ
|
NO |
|
Recruit Holdings Co Ltd
TSE:6098
|
JP |
|
P
|
PepsiCo Inc
XETRA:PEP
|
US |
|
EOG Resources Inc
NYSE:EOG
|
US |
|
Taiwan Semiconductor Manufacturing Co Ltd
NYSE:TSM
|
TW |
|
S
|
Seagen Inc
XBER:SGT
|
US |
|
T
|
Teck Resources Ltd
TSX:TECK.A
|
CA |
|
Y
|
Yokohama Rubber Co Ltd
XBER:YRB
|
JP |
Bankruptcy Probability
Ultragenyx Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ultragenyx Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ultragenyx Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ultragenyx Pharmaceutical Inc has total debt of 1.1B USD. This includes both short-term (0 USD) and long-term (1.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
